Pipazetate
Clinical data
Dipect, Lenopect, Selvignon, Selvigon, Theratuss, Toraxan
Other names
Pipazethate; D-254; LG-254; SKF-70230A; SQ-15874
oral
Legal status
Identifiers
2-(2-piperidin-1-ylethoxy)ethyl 10H-pyrido[3,2-b][1,4]benzothiazine-10-carboxylate
PubChem CID
YYYCompTox Dashboard (EPA)
Chemical and physical data
C21H25N3O3S
399.51 g·mol−1
3D model (JSmol)
O=C(OCCOCCN1CCCCC1)N3c4c(Sc2c3nccc2)cccc4
InChI=1S/C21H25N3O3S/c25-21(27-16-15-26-14-13-23-11-4-1-5-12-23)24-17-7-2-3-8-18(17)28-19-9-6-10-22-20(19)24/h2-3,6-10H,1,4-5,11-16H2 Y
Key:DTVJXCOMJLLMAK-UHFFFAOYSA-N Y
Pipazetate (INNTooltip International Nonproprietary Name) (brand names Dipect, Lenopect, Selvigon, Theratuss, Toraxan), or pipazethate (USANTooltip United States Adopted Name), is a 1-azaphenothiazine drug that was briefly marketed as a cough suppressant.[1][2] It binds to the sigma-1 receptor with an IC50 value of 190 nM.[3] It also has local anesthetic action, and in large doses can produce seizures.[4]
As the brand name Theratuss, it was approved by the FDA in 1962, on evidence of safety only. It was withdrawn from the US market in 1972 when the manufacturer, Bristol Myers Squibb, failed to produce evidence of efficacy.[5] Clinical studies showed that it did not decrease cough frequency at recommended dosages.[6]
Infrequent side effects include nausea, vomiting, drowsiness, fatigue, rash, tachycardia and seizures.[6]
Note: 1-azaphenothiazine is also used for making Prothipendyl & Isothipendyl.
The reaction of 1-azaphenothiazine [261-96-1] (1) with phosgene gives 1-azaphenothiazine-10-carbonyl chloride [94231-78-4] (2). The reaction of this reactive intermediate with 2-[2-(piperidyl)ethoxy]ethanol [3603-43-8] (3) gives the ester, thus completing the synthesis of Pipazethate (4).
Other
Unsorted
See also: Receptor/signaling modulators
Others
This drug article relating to the respiratory system is a stub. You can help Wikipedia by expanding it.
